Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / MED BREAKTHGH
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
701,962
-
Shares change
-
-48,065
-
Total reported value, excl. options
-
$16,118,143
-
Value change
-
-$1,261,233
-
Put/Call ratio
-
0%
-
Number of buys
-
12
-
Number of sells
-
-18
-
Price
-
$22.92
Significant Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q4 2016
36 filings reported holding SBIO - ALPS ETF TR - MED BREAKTHGH as of Q4 2016.
ALPS ETF TR - MED BREAKTHGH (SBIO) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 701,962 shares
.
Largest 10 shareholders include RAYMOND JAMES & ASSOCIATES (145,822 shares), BANK OF AMERICA CORP /DE/ (124,587 shares), CITADEL ADVISORS LLC (64,035 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (61,347 shares), UBS Group AG (57,452 shares), GOLDMAN SACHS GROUP INC (50,036 shares), JANE STREET GROUP, LLC (45,633 shares), LPL Financial LLC (26,827 shares), ROYAL BANK OF CANADA (22,305 shares), and Prospera Financial Services Inc (18,275 shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.